RxDoctor Payments Data

Asem Rimawi, MD

Clinical Cardiac Electrophysiology · Lafayette, INNPI 1629005913

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,725 of the $10,237 with a category attached, or 65.7%. Medtronic accounts for 66.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $4,587 and has fallen 88.8% since, to $516 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.

$10,237in general payments, 2019–2025

Across 104 payments — averaging $98.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Boston Scientific$1K
  • Biosense Webster, Inc.$838
  • Medical Device Business Services, Inc.$830
  • Abbott$153
  • Novartis$126
  • plus $228 from 9 others

What the payments were for

  • Travel & lodging$6,72566%
  • Food & beverage$3,51234%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,237 in reported general payments places this provider in the 35th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$194,554
Medicare patients
720
Services billed
2,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban456$374,076
XareltoRivaroxaban87$86,441
MultaqDronedarone Hcl61$60,359
EntrestoSacubitril/Valsartan39$32,430
Amiodarone Hcl371$7,654
Diltiazem 24hr Er (Cd)Diltiazem Hcl100$2,439
Flecainide Acetate39$1,935
Metoprolol Succinate190$1,867
Dabigatran EtexilateDabigatran Etexilate Mesylate12$1,822
Nebivolol Hcl22$1,062
Carvedilol99$878
Metoprolol Tartrate251$871
Lisinopril98$580
SotalolSotalol Hcl21$516
Amlodipine Besylate88$463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$374,076456 claims
Johnson & JohnsonXarelto$41$86,44187 claims
NovartisEntresto$126$32,43039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

Other clinical cardiac electrophysiology in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →